← The Wire
OPRXNasdaq
OptimizeRx Corp
Services-Business Services, NEC · NV · CIK 1448431
OptimizeRx provides digital healthcare technology solutions for life sciences brands to engage with patients and providers
red 8-K · 90d
$98M
Market cap
$5.43
Last close
+6.0%
1D
+16.0%
5D
359K
Volume
Price · last 39 sessions-19.8%
May 4L $4.54 · H $6.77Jun 29
458
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 12, 20268-KExecutive ChangeJun 5, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSJun 1, 202610-Q10-QMay 13, 20268-KMaterial Agreement · Agreement TerminatedMay 12, 2026DEF 14APROXY STATEMENTApr 30, 20268-KExecutive Change · Reg FD DisclosureApr 9, 20268-KAuditor ChangeMar 30, 202610-K10-KMar 12, 20268-KMaterial Agreement · Results of OperationsMar 5, 202610-Q10-QNov 7, 20258-KResults of OperationsNov 6, 20258-KExecutive Change · Reg FD DisclosureAug 19, 202510-Q10-QAug 8, 20258-KResults of OperationsAug 7, 20258-KExecutive Change · Reg FD DisclosureJun 24, 20258-KShareholder VoteJun 16, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 12, 2025DEF 14APROXY STATEMENTApr 30, 20258-KReg FD Disclosure · Company UpdateApr 18, 202510-KANNUAL REPORTMar 20, 20258-KResults of OperationsMar 12, 2025DEFA14ASOLICITING MATERIAL UNDER 240.14A-12Mar 11, 20258-KExecutive Change · Reg FD DisclosureMar 10, 20258-KExecutive ChangeJan 10, 20258-KExecutive Change · Reg FD DisclosureDec 23, 202410-QQUARTERLY REPORTNov 14, 2024SC 13GOPRX 13GNov 14, 20248-KResults of OperationsNov 13, 2024SC 13GSC 13GNov 13, 202410-QQUARTERLY REPORTAug 15, 20248-KResults of OperationsAug 8, 20248-KExecutive Change · Shareholder VoteJun 7, 202410-QQUARTERLY REPORTMay 15, 20248-KResults of OperationsMay 14, 20248-KResults of OperationsApr 29, 2024DEF 14APROXY STATEMENTApr 29, 20248-KResults of OperationsApr 18, 202410-KANNUAL REPORTApr 15, 20248-KMaterial Agreement · Results of OperationsApr 2, 20248-KResults of OperationsMar 11, 2024SC 13GACQUISITION OF BENEFICIAL OWNERSHIPFeb 14, 20248-KExecutive Change · Reg FD DisclosureJan 26, 20248-K/ACompany UpdateJan 5, 2024SC 13GSC 13GDec 29, 2023SC 13GSCHEDULE 13GNov 28, 202310-QQUARTERLY REPORTNov 14, 20238-KResults of OperationsNov 6, 20238-KExecutive Change · Material AgreementOct 25, 20238-KExecutive Change · Material AgreementOct 16, 202310-QQUARTERLY REPORTAug 14, 20238-KResults of OperationsAug 14, 2023SC 13GSCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIPJun 9, 20238-KShareholder VoteJun 7, 202310-QQUARTERLY REPORTMay 12, 20238-KResults of OperationsMay 10, 2023DEF 14APROXY STATEMENTApr 25, 20238-KCompany UpdateMar 14, 202310-KANNUAL REPORTMar 10, 202310-Q/AAMENDMENT NO. 1 TO FORM 10-QMar 10, 202310-Q/AAMENDMENT NO. 1 TO FORM 10-QMar 10, 202310-Q/AAMENDMENT NO. 1 TO FORM 10-QMar 10, 202310-K/AAMENDMENT NO. 1 TO FORM 10-KMar 10, 20238-KResults of OperationsMar 8, 202310-QQUARTERLY REPORTNov 8, 20228-KResults of OperationsNov 8, 20228-K/AResults of OperationsAug 10, 202210-QQUARTERLY REPORTAug 9, 20228-KResults of OperationsAug 9, 20228-KShareholder VoteJun 13, 20228-KCompany UpdateMay 17, 202210-QQUARTERLY REPORTMay 9, 20228-KResults of OperationsMay 4, 2022DEF 14ADEFINITIVE PROXY STATEMENTApr 25, 20228-KEquity IssuanceMar 17, 20228-KExecutive Change · Company UpdateMar 4, 202210-KANNUAL REPORTFeb 28, 20228-KResults of OperationsFeb 24, 20228-KResults of OperationsFeb 15, 2022
Insider Activity
In the 90 days to Dec 19, 2025: 2 sold $49K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Stelmakh EdwardChief Finance & Strat Officer | Sell | 1,388 | $13.51 | $19K |
| Oct 3, 2025 | Silvestro Stephen LChief Executive Officer | Sell | 1,620 | $18.75 | $30K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance